Short Summary
Nike challenged U.S. Patent No. 9,295,288 held by SherryWear regarding intimate apparel design features. The petitioner argues that the claimed bra elements are obvious combinations of prior art references like Barg and York. This challenge tests the boundaries of routine design choices in the apparel industry.
Detailed Summary
Nike, Inc., filed a petition challenging claims 1-4 and 11-12 of U.S. Patent No. 9,295,288 held by SherryWear, LLC, asserting obviousness under 35 U.S.C. § 103. The petitioner contends that the combination of features disclosed in prior art references (including Barg, York, Handras, and Pintor) would have been a routine design modification for a Person Having Ordinary Skill in the Art (POSA). Specifically, Nike argues that combinations such as York in view of Pintor are motivated by commercial benefits inherent to bra construction.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before local courts. Understanding the court's reasoning in Nike, Inc. vs SherryWear, LLC is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
TESLA, INC.vsiQar Inc.
The Board found all challenged claims unpatentable over combinations of Kudo-325 and Kudo-066. The petitioner successfully argued that the prior art combination teaches or suggests the necessary elements for destination prediction and power management in vehicles. This final decision affirms the obviousness rejection against iQar Inc.'s patent.
Apple Inc.vsApex Beam Technologies LLC
Apple and Apex Beam Technologies jointly moved to terminate sixteen inter‑partes review proceedings after reaching a settlement. The PTAB granted the motion, treating the settlement agreements as confidential.
Apple Inc.vsVampire Labs, LLC
Apple has filed an IPR petition challenging all 14 claims of Vampire Labs' battery‑charging patent, arguing that the claims are obvious over prior art (Stephens, Horowitz, and Toya) and that discretionary denial is unwarranted. The petition seeks institution of the proceeding and cancellation of the claims.
NIUM PTE. LTD.vsIntercurrency Software LLC
NIUM PTE. LTD. and Intercurrency Software LLC jointly moved to terminate IPR2025-01586 after reaching a confidential settlement over a foreign‑exchange trading patent.
Imperative Care, Inc.vsInari Medical, Inc. et al.
The PTAB instituted an inter partes review of Inari Medical’s 11,697,012 patent covering hemostasis valves after finding Imperative Care’s petition shows a reasonable likelihood of success on at least one claim.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.